News
New Medication Release of Tonmya
The FDA has approved Tonmya (cyclobenzaprine HCl sublingual tablet) for the treatment of fibromyalgia in…
Carlisle Medical Will Be Exhibiting at the 2025 Alabama Workers Compensation Society Conference (AWCS)
Carlisle Medical Will Be Exhibiting at the 2025 Alabama Workers Compensation Society Conference (AWCS) on…
Launch of Generic Entresto (sacubitril/valsartan) Tablets
Generic Entresto (sacubitril/valsartan) has recently been approved by the FDA and released in 24mg/26mg, 49mg/51mg…
Nevada Adopts ODG Drug Formulary
Bipartisan legislation makes Nevada the thirteenth state to adopt an ODG tool for workers’ comp…
Carlisle Medical Will Be Exhibiting At The 2025 Florida RIMS Educational Conference
Carlisle Medical is excited to announce that we will be exhibiting at the 2025 Florida…
Carlisle Medical Will Be Exhibiting At The 2025 IWCI Annual Seminar
Carlisle Medical is excited to announce that we will be exhibiting at the 2025 IWCI…
Launch of Brilinta® (Ticagrelor) Tablets
Generic Brilinta® (Ticagrelor) has been approved by the FDA. Ticagrelor tablets are indicated to reduce…
Carlisle Medical Will Be Exhibiting At The 2025 SBWC Annual Educational Conference
Carlisle Medical is excited to announce that we will be exhibiting at the 2025 State…
Launch of Generic Xarelto (Rivaroxaban) Tablets
Generic Xarelto (Rivaroxaban) has recently been approved by the FDA and released in 2.5 mg…
Carlisle Medical Will Be Exhibiting At The 2025 Tennessee Workers’ Compensation Educational Conference Copy
Carlisle Medical will be exhibiting at the 2025 Tennessee Workers’ Compensation Educational Conference on June…
